Gregoire Le Gal
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 356 publications
Perioperative Management of Anticoagulation in Patients With Mechanical Heart Valves.
Journal: JAMA network open
Published: September 04, 2026
Genomic Evidence Links Inflammation to Residual Pulmonary Vascular Obstruction and Risk of Pulmonary Embolism Recurrence.
Journal: medRxiv : the preprint server for health sciences
Published: July 17, 2026
Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial.
Journal: Circulation
Published: July 13, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism. Reply.
Journal: The New England journal of medicine
Published: June 10, 2026
Is it still legitimate to prescribe a DOAC other than apixaban in venous thromboembolism?
Journal: La Revue de medecine interne
Published: March 25, 2026
Timing, Translation, and Preparedness: Lessons Learned From COVID-19 Anticoagulation in Noncritically Ill Hospitalized Patients.
Journal: Journal of the American College of Cardiology
Published: March 16, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
Journal: The New England journal of medicine
Published: March 11, 2026
Elevated on-treatment D-dimer level is associated with major bleeding during extended anticoagulation for venous thromboembolism.
Journal: Haematologica
Published: January 26, 2026
Last Updated: 09/26/2026